Leadership Team

At Polpharma Biologics, our commitment to excellence begins at the top.

With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals, our international management team brings both knowledge and passion to every project.

Polpharma Biologics Group BV  

Jerzy Starak

Jerzy Starak is the founder and Chairman of Polpharma Biologics Group B.V. Mr Starak is an investor in the pharma, biotech, consumer goods and real estate sectors across Europe and is a visionary, who does not lack the courage, determination and perseverance in taking on ambitious challenges.

Hannes Teissl

Hannes is a Vice Chairman of Polpharma Biologics B.V., a company which he was instrumental in establishing over the last 7 years. Hannes is a seasoned biopharmaceutical executive with a track record in general management, business turnaround, finance, business development and M&A.

Joerg Windisch 

Dr. Joerg Windisch, President & CEO of Polpharma Biologics Group B.V., has around 25 years of experience in the development, manufacture and regulatory licensure of biologic therapies. Prior to joining Polpharma Biologics, Dr. Windisch served as the Chief Operating Officer (COO) for Affimed. Before that, Dr. Windisch spent almost 20 years at Novartis/Sandoz where he most recently served as CSO for Sandoz Biopharmaceuticals. He was a key figure in developing the first biosimilars approved in Europe and the US.

Polpharma Biologics S.A. 

Jan Krzewinski


Jan Krzewiński is the General Manager Gdańsk and COO of Polpharma Biologics. Prior to his current position Jan held various roles at Polpharma. and previously worked at Mid Europa Partners, a private equity fund, where he was responsible for executing and monitoring investments including Lux Med, Diagnostyka, Alpha Medical and PKL. Jan serves on the board of the EFC Foundation and holds a BSc from the London School Economics and M.A. from Johns Hopkins University (SAIS).

Dr Adriana Kiędzierska-Mencfeld


Dr. Kiędzierska-Mencfeld is the Vice President TechOps Gdansk. She has more than 10 years of experience in recombinant protein purification and expression in both prokaryotic and eukaryotic systems, and six years of experience in the development and GMP production of biosimilars. Prior to joining Polpharma Biologics she spent four years as Head of GMP Production at Mabion S.A.

Polpharma Biologics Warsaw Sp. z o.o.

Frederic Papp


Frederic Papp is the General Manager Warsaw and CTO of Polpharma Biologics. He has over 25 years of professional experience. Prior to joining Polpharma Biologics, Frederic worked at Merck as Site Head of a Biotech Plant (Spain) as well as Head of Global Biotech Network Operations (Switzerland), performing also other senior global and local roles.

Frank Ternes


Frank Ternes is the Global Head of CDMO for Polpharma Biologics and member of the management board of Polpharma Biologics Warsaw. Frank has over 30 years of professional experience. He was at Boehringer Ingelheim for over 25 years, working as SVP Contract Manufacturing Business, SVP Biotech & Operations and VP Supply Chain Management. Prior to joining Polpharma Biologics, Frank served as Chief Business Officer at Biotechpharma.

Wojciech Kowalski


Wojciech is a Member of the Management Board of Polpharma Biologics Warsaw overseeing the business functions of the Warsaw site. Wojciech joined Polpharma Biologics from Bioton S.A where her served as the Global Diabetes Business Unit Director. Before that Wojciech spent over 10 years at Novo Nordisk where he spent over four years as the General Manager for Poland. Wojciech holds a M.Sc. Eng. in Biotechnology, Biochemistry and Genetic Engineering from the University of Łódź and an MBA from the Leon Kozminski Academy.

Igor Kostyszyn


Igor is a Member of the Management Board of Polpharma Biologics Warsaw and Finance Director of the site. Igor has overseen the construction of the Warsaw site from the beginning. Before joining the Company, Igor spent many years as the Finance Director of Polfa Warszawa, part of Polpharma Group. Igor holds an M.A. in economics from the University of Gdansk

Polpharma Biologics Utrecht BV

Jonathan Robinson


Jonathan Robinson is the General Manager Utrecht. Jonathan has 28 years experience in the Pharma and Biotech sectors. He has moved through various leadership roles in facility start up and production management of both small and large molecule manufacturing sites at Searle, Chirex, and Avecia Billingham (now Fujifilm).

Louis Boon


Dr. Louis Boon is Chief Scientific Officer at Polpharma Biologics Utrecht formerly Bioceros and a founder of Bioceros BV. He is experienced in molecular and cellular immunology and therapeutic antibody development and has been involved in the trajectory of preclinical preparation and design of first-into-man studies using therapeutic antibodies.

Emile van Corven


Dr. Emile van Corven is Chief Development Officer at Polpharma Biologics Utrecht. He started his career in academia, and after 9 years he moved into the biotech industry in 1992. Before joining the current company in 2015 he has had various leadership roles in pharmaceutical product development and GMP manufacturing of complex biologicals (recombinant proteins and vaccines) at Pharming, Crucell, and J&J.

About Us | AB

About Us Advisory Board

At Polpharma Biologics, our commitment to excellence begins at the top. With decades of combined experience at some the world largest pharmaceutical companies our advisory board brings immense expertise.